Abstract
This study pertains to measure differences in bacterial communities along the wastewater pathway, from sewage sources through the environment. Our main focus was on taxa which include pathogenic genera, and genera harboring antibiotic resistance (henceforth referred to as “target taxa”). Our objective was to measure the relative abundance of these taxa in clinical wastewaters compared to non-clinical wastewaters, and to investigate what changes can be detected along the wastewater pathway. The study entailed a monthly sampling campaign along a wastewater pathway, and taxa identification through 16S rRNA amplicon sequencing. Results indicated that clinical and non-clinical wastewaters differed in their overall bacterial composition, but that target taxa were not enriched in clinical wastewater. This suggests that treatment of clinical wastewater before release into the wastewater system would only remove a minor part of the potential total pathogen load in wastewater treatment plants. Additional findings were that the relative abundance of most target taxa was decreased after wastewater treatment, yet all investigated taxa were detected in 68% of the treated effluent samples—meaning that these bacteria are continuously released into the receiving surface water. Temporal variation was only observed for specific taxa in surface water, but not in wastewater samples.
Highlights
We analyzed the bacterial compositions along a whole wastewater pathway
One other study reported a direct comparison between hospital wastewater, domestic wastewater and influent [40], and showed that these three waters were contained in the same cluster, with domestic wastewater more similar to hospital wastewater than to influent
We found that clinical and non-clinical wastewaters significantly differ in their composition, but this difference was mainly caused by genera not included within the target taxa
Summary
Antimicrobial resistance (AMR) is recognized as a major threat to public health at a global scale [1]. The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) play an important role in nosocomial infections, pathogenesis, and AMR spread [2,3]. In. 2018 the World Health Organization (WHO) published a global priority list of antimicrobialresistant bacteria (AMRB) for which research and development of new antibiotics is urgently needed [4]. The bacterial composition in the gut can be altered [5,6] and even be enriched in AMRB [7]. Some bacteria are found to thrive after
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.